Viral Hemorrhagic Fever Consortium

Updates & Blogs

Corgenix Gains CE Mark for ReLASV® Antigen Rapid Test for Diagnosis of Lassa Fever

Sunday, May 12, 2013 - 13:20
VHFC Investigators take part in 11th Annual ASM Biodefense and Emerging Diseases Research Meeting

Sunday, April 7, 2013 - 14:33
Publication - Lassa fever: why there are more public health questions than answers

Sunday, April 7, 2013 - 14:09
The Virus Hunter - Erica Ollmann Saphire featured in U-T San Diego

Tuesday, January 22, 2013 - 20:16

Corgenix Gains CE Mark for ReLASV® Antigen Rapid Test for Diagnosis of Lassa Fever

VHFC partner, Corgenix Medical Corporation, has developed the first commercialized diagnostic test that enables rapid diagnosis of Lassa viral hemorrhagic fever. Read more

About the Consortium

Updates & Blogs

Featured Story

Corgenix Gains CE Mark for ReLASV® Antigen Rapid Test for Diagnosis of Lassa Fever